The store will not work correctly when cookies are disabled.
4-Amino-N1-(beta-D-ribofuranosyl)-pyrrolo[2,3-b]pyridine
ID: ALA4436060
Cas Number: 83683-90-3
PubChem CID: 128557
Max Phase: Preclinical
Molecular Formula: C12H15N3O4
Molecular Weight: 265.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C12H15N3O4/c13-7-1-3-14-11-6(7)2-4-15(11)12-10(18)9(17)8(5-16)19-12/h1-4,8-10,12,16-18H,5H2,(H2,13,14)/t8-,9-,10-,12-/m1/s1
Standard InChI Key: ICSYNCVSXUEZDG-DNRKLUKYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
5.5181 -3.0459 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7381 -3.2935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1743 -3.5164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8388 -3.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5788 -2.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4904 -4.0736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7616 -2.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0777 -2.8230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6732 -4.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4132 -3.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5817 -3.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2610 -4.3212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6684 -4.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0039 -4.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9816 -4.7422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2379 -2.8849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1903 -4.7463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6332 -3.0583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9233 -3.4627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 1 1 0
4 3 2 0
5 7 2 0
6 2 1 0
7 1 1 0
8 2 1 0
9 6 1 0
10 8 1 0
11 4 1 0
12 3 1 0
13 14 1 0
14 12 2 0
6 15 1 6
16 11 1 0
9 17 1 6
10 18 1 1
4 5 1 0
9 10 1 0
13 11 2 0
18 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.27 | Molecular Weight (Monoisotopic): 265.1063 | AlogP: -0.77 | #Rotatable Bonds: 2 |
Polar Surface Area: 113.76 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.46 | CX Basic pKa: 7.74 | CX LogP: -1.17 | CX LogD: -1.60 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.57 | Np Likeness Score: 1.02 |
References
1. Lin C, Hulpia F, da Silva CF, Batista DDGJ, Van Hecke K, Maes L, Caljon G, Soeiro MNC, Van Calenbergh S.. (2019) Discovery of Pyrrolo[2,3-b]pyridine (1,7-Dideazapurine) Nucleoside Analogues as Anti-Trypanosoma cruzi Agents., 62 (19): [PMID:31495177] [10.1021/acs.jmedchem.9b01275] |
2. Lin C, Jaén Batista DDG, Mazzeti AL, Donola Girão R, de Oliveira GM, Karalic I, Hulpia F, Soeiro MNC, Maes L, Caljon G, Van Calenbergh S.. (2022) N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation., 231 [PMID:35144125] [10.1016/j.ejmech.2022.114165] |